Peregrine Pharmaceuticals | PPHM - Trade Creditors


Peregrine Pharmaceuticals reported $9.25M in Trade Creditors for its fiscal quarter ending in October of 2024.



Trade Creditors Change Date
Agenus USD 82.99M 2.3M Dec/2025
Amgen USD 20.89B 1.25B Dec/2025
AstraZeneca USD 25.28B 252M Dec/2025
BioCryst Pharmaceuticals USD 15.83M 10.26M Dec/2025
Bristol-Myers Squibb USD 4.29B 1.14B Sep/2025
Celldex Therapeutics USD 1.18M 3.09M Dec/2025
Eli Lilly USD 5.38B 1.12B Dec/2025
GlaxoSmithKline GBP 15.38B 294M Dec/2025
Intrexon USD 4.85M 3.12M Jun/2024
Karyopharm Therapeutics USD 4M 1.39M Dec/2025
MacroGenics USD 4.79M 1.15M Dec/2025
MannKind USD 9.03M 1.76M Dec/2025
Merck USD 4.15B 102M Sep/2025
Minerva Neurosciences USD 640K 305K Dec/2025
Novartis USD 4.46B 99M Dec/2025
Novavax USD 24.58M 9.35M Dec/2025
Repligen USD 30.01M 584K Dec/2025
Roche Holding CHF 5.78B 1.27B Dec/2025
Xencor USD 10.83M 1.75M Dec/2025